LIMK1 and neoplasm: A significant worse overall survival rate was observed for patients with high levels of LIMK1 in all tumor stages, early stage, and late stage (P < 0.001, P < 0.01, and P < 0.01, respectively), indicating that high level LIMK1 was an unfavorable prognostic indicator in patients with CRC.